Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
The American Journal of Surgical Pathology
|
May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study
Sabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
The Journal of Pathology
|
April 26, 2019
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas
Monica Brenca, Silvia Stacchiotti, Kelly Fassetta, et al.
The Lancet. Oncology
|
April 13, 2016
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
Dario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
Eclinicalmedicine
|
May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
Alessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
Molecular Cancer Therapeutics
|
October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study
Javier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
JAMA Oncology
|
March 30, 2023
Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial
Roberta Sanfilippo, Nadia Hindi, Josefina Cruz Jurado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
JAMA Oncology
|
October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review
César Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Synaptophysin expression in <sup>V600EBRAF-</sup>mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
Matteo Fassan, Massimo Milione, Giulia Maddalena, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
The American Journal of Surgical Pathology
|
May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study
Sabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
The Journal of Pathology
|
April 26, 2019
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas
Monica Brenca, Silvia Stacchiotti, Kelly Fassetta, et al.
The Lancet. Oncology
|
April 13, 2016
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
Dario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
Eclinicalmedicine
|
May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
Alessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
Molecular Cancer Therapeutics
|
October 23, 2013
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study
Javier Martin-Broto, Antonio M Gutierrez, Rafael F Ramos, et al.
JAMA Oncology
|
March 30, 2023
Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial
Roberta Sanfilippo, Nadia Hindi, Josefina Cruz Jurado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
JAMA Oncology
|
October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review
César Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2021
Synaptophysin expression in <sup>V600EBRAF-</sup>mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
Matteo Fassan, Massimo Milione, Giulia Maddalena, et al.
Page
of 10